COLL vs KR
Collegium Pharmaceutical Inc (COLL) versus Kroger Company (KR) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Kroger Company (KR) is a grocery stores company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported KR revenue for 2025-02-01 was $147.12B. Net income was $2.67B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. KR currently screens at market cap $46.17B and trailing P/E 19.0.
Not investment advice. Open the COLL and KR stock pages for the full models.
Not investment advice.